Found: 5
Select item for more details and to access through your institution.
Impact of MRD Eradication on Survival Outcomes in CLL Patients with Different IGHV Mutation Status.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. S273, doi. 10.1016/j.clml.2019.07.203
- By:
- Publication type:
- Article
Efficacy of Ibrutinib in the Treatment of First Early Relapses of CLL.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2018, v. 18, p. S216, doi. 10.1016/j.clml.2018.07.080
- By:
- Publication type:
- Article
Prospective Evaluation of Safety and Efficacy of BR Regimen in Previously Untreated CLL Patients.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2016, v. 16, p. S46, doi. 10.1016/j.clml.2016.07.067
- By:
- Publication type:
- Article
Five‐year survival follow‐up of a phase III randomised trial comparing ofatumumab versus physicians' choice for bulky fludarabine‐refractory chronic lymphocytic leukaemia: a short report.
- Published in:
- British Journal of Haematology, 2020, v. 189, n. 4, p. 689, doi. 10.1111/bjh.16429
- By:
- Publication type:
- Article
Impact of age and comorbidities on the efficacy of FC and FCR regimens in chronic lymphocytic leukemia.
- Published in:
- Annals of Hematology, 2018, v. 97, n. 11, p. 2153, doi. 10.1007/s00277-018-3409-3
- By:
- Publication type:
- Article